Zobrazeno 1 - 10
of 184
pro vyhledávání: '"Fordham von Reyn"'
Autor:
Elizabeth Talbot, Patricia Munseri, Pedro Teixeira, Mecky Matee, Muhammad Bakari, Timothy Lahey, Fordham von Reyn
Publikováno v:
PLoS ONE, Vol 7, Iss 3, p e32876 (2012)
Tuberculosis is the most common cause of death among patients with HIV infection living in tuberculosis endemic countries, but many cases are not diagnosed pre-mortem. We assessed the test characteristics of urinary lipoarabinomannan (LAM) and predic
Externí odkaz:
https://doaj.org/article/3d6ac9fe72864a4187e7e15ad9f7f259
Autor:
Maryam A Amour, Christiaan A Rees, Patricia J Munseri, Jamila Said, Albert K Magohe, Mecky Matee, Elizabeth A Talbot, Robert D Arbeit, Kisali Pallangyo, C Fordham von Reyn
Publikováno v:
PLoS ONE, Vol 17, Iss 6, p e0268685 (2022)
BackgroundProspective studies of interferon-gamma release assays (IGRA) on healthy subjects in tuberculosis-endemic regions have not examined the long-term variability of serial assays. This issue is relevant to the interpretation of tuberculosis (TB
Externí odkaz:
https://doaj.org/article/ec5b57f47c29471eb2f98340c7c19c07
Autor:
Olivia F. Hunter, Furaha Kyesi, Amrit Kaur Ahluwalia, Zeinabou Niamé Daffé, Patricia Munseri, C. Fordham von Reyn, Lisa V. Adams
Publikováno v:
BMC Infectious Diseases, Vol 20, Iss 1, Pp 1-1 (2020)
An amendment to this paper has been published and can be accessed via the original article.
Externí odkaz:
https://doaj.org/article/2b7f47a81a684265a6daaaeb113741d4
Autor:
Tereza Masonou, David A Hokey, Timothy Lahey, Alice Halliday, Luis C Berrocal-Almanza, Wendy F Wieland-Alter, Robert D Arbeit, Ajit Lalvani, C Fordham von Reyn
Publikováno v:
PLoS ONE, Vol 14, Iss 5, p e0217091 (2019)
BACKGROUND:DAR-901 is an inactivated whole cell tuberculosis booster vaccine, prepared using a new scalable, broth-grown method from the master cell bank of SRL172, a vaccine previously shown to prevent tuberculosis. This study examined whether DAR-9
Externí odkaz:
https://doaj.org/article/88ddceddb42140d889ed399b458a473e
Autor:
Chelsea E. Modlin, BA, Helga Naburi, MD, Kristy M. Hendricks, ScD, RD, Goodluck Lyatuu, MD, Josphine Kimaro, RD, Lisa V. Adams, MD, Paul E. Palumbo, MD, C. Fordham von Reyn, MD
Publikováno v:
International Journal of Maternal and Child Health and AIDS, Vol 2, Iss 2, Pp 220-228 (2014)
Background: Poor nutrition has been associated with impaired immunity and accelerated disease progression in HIV- infected children. The aim of this study was to quantify the levels of nutrient intake in HIV-infected children and compare these to s
Externí odkaz:
https://doaj.org/article/b51e877b2c3d4a7d9975a3a2ad39f632
Autor:
C Fordham von Reyn, Timothy Lahey, Robert D Arbeit, Bernard Landry, Leway Kailani, Lisa V Adams, Brenda C Haynes, Todd Mackenzie, Wendy Wieland-Alter, Ruth I Connor, Sue Tvaroha, David A Hokey, Ann M Ginsberg, Richard Waddell
Publikováno v:
PLoS ONE, Vol 12, Iss 5, p e0175215 (2017)
Development of a tuberculosis vaccine to boost BCG is a major international health priority. SRL172, an inactivated whole cell booster derived from a non-tuberculous mycobacterium, is the only new vaccine against tuberculosis to have demonstrated eff
Externí odkaz:
https://doaj.org/article/72ed7a4d28b543bb9c08543d05916f7e
Autor:
Timothy Lahey, C. Fordham von Reyn
Publikováno v:
Tuberculosis and Nontuberculous Mycobacterial Infections. :162-181
Several tuberculosis vaccines have been shown to reduce the risk of disease and death due to tuberculosis in humans, but only one is used in global immunization programs: Mycobacterium bovis bacillus Calmette-Guerin (BCG). The development of new tube
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::66d3a9580bdceeaf3ae129dca372bb35
https://doi.org/10.1128/9781555817138.ch10
https://doi.org/10.1128/9781555817138.ch10
Autor:
Wendy Wieland-Alter, Robert D. Arbeit, Isaac Maro, Lisa V. Adams, Albert Magohe, Chris Bailey-Kellogg, Jamila Said, Susan Tvaroha, Christiaan A. Rees, Keiko Nakamura, Patricia Munseri, Mecky Matee, Todd A. MacKenzie, Maryam Amour, C. Robert Horsburgh, Kisali Pallangyo, C. Fordham von Reyn
Publikováno v:
Vaccine. 38:7239-7245
Background SRL172 prevented disease due to Mycobacterium tuberculosis in a Phase 3 trial. DAR-901 represents a scalable manufacturing process for SRL172. We sought to determine if DAR-901 would prevent infection with M. tuberculosis among BCG-primed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8666dd50e8e853daeb5fe4db8c02af23
https://doi.org/10.1016/j.vaccine.2020.09.055
https://doi.org/10.1016/j.vaccine.2020.09.055
Autor:
Maryam Amour, Dwan W B Pineros, C. Fordham von Reyn, Kisali Pallangyo, Christiaan A. Rees, Patricia Munseri, Mecky Matee, Albert Magohe, Jamila Said
Publikováno v:
BMC Infectious Diseases, Vol 20, Iss 1, Pp 1-10 (2020)
BMC Infectious Diseases
BMC Infectious Diseases
Background Ratios of different immune cell populations (i.e., monocyte-to-lymphocyte, neutrophil-to-lymphocyte, and platelet-to-lymphocyte ratios) have been studied as a means of predicting future tuberculosis (TB) disease risk or to assist in the di
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ff4b2978f84d5785a9dfc8434445cf4
http://link.springer.com/article/10.1186/s12879-020-05331-w
http://link.springer.com/article/10.1186/s12879-020-05331-w
Autor:
Timothy Lahey, Dominick Laddy, Krystal Hill, Jacqueline Schaeffer, Alison Hogg, James Keeble, Belinda Dagg, Mei Mei Ho, Robert D Arbeit, C Fordham von Reyn
Publikováno v:
PLoS ONE, Vol 11, Iss 12, p e0168521 (2016)
BACKGROUND:The development of a novel tuberculosis vaccine is a leading global health priority. SRL172, an inactivated, whole-cell mycobacterial vaccine, was safe, immunogenic and reduced the incidence of culture-confirmed tuberculosis in a phase III
Externí odkaz:
https://doaj.org/article/752dbd23edf44389a36256452cb80ba1